Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan;95(1):e28272.
doi: 10.1002/jmv.28272. Epub 2022 Nov 14.

Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996)

Joachim Rosenbauer  1   2 , Anna Stahl-Pehe  1   2 , Sabrina Schlesinger  1   2 , Oliver Kuß  1   2
Affiliations
Comment

Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996)

Joachim Rosenbauer et al. J Med Virol. 2023 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Random‐effects meta‐analysis of the risk of (A) diabetic ketoacidosis (DKA) and (B) severe diabetic ketoacidosis (sDKA) at onset of pediatric type 1 diabetes in the pandemic versus the pre‐pandemic period—Reanalysis of studies included in fig. 3A of Rahmati 2022. Some numbers of (s)DKA/T1D cases used in Rahmati 2022 were revised to resemble the data given in the following original publications: Boboc 2021, Goldman 2022, Gottesmann 2022, Hawkes 2021, Hernandez Herrero 2021, Ho 2021. Supporting Information: Table S1 gives details of the data correction. Prevalence ratio: Ratio of DKA prevalence in pandemic versus pre‐pandemic period (termed risk ratio in Rahmati 1 ). τ 2: between‐study variance. I 2: statistic of between‐study heterogeneity. H 2: statistic of between‐study heterogeneity (=1/(1 − I 2)). Q, p: Cochran's Q statistic for testing heterogeneity between studies and corresponding p value. z, p: z‐statistic for testing the hypothesis of a zero pooled effect and corresponding p value. Qb, p: test statistic for testing between‐group differences of the pooled effect and corresponding p value.
Figure 1
Figure 1
Random‐effects meta‐analysis of the risk of (A) diabetic ketoacidosis (DKA) and (B) severe diabetic ketoacidosis (sDKA) at onset of pediatric type 1 diabetes in the pandemic versus the pre‐pandemic period—Reanalysis of studies included in fig. 3A of Rahmati 2022. Some numbers of (s)DKA/T1D cases used in Rahmati 2022 were revised to resemble the data given in the following original publications: Boboc 2021, Goldman 2022, Gottesmann 2022, Hawkes 2021, Hernandez Herrero 2021, Ho 2021. Supporting Information: Table S1 gives details of the data correction. Prevalence ratio: Ratio of DKA prevalence in pandemic versus pre‐pandemic period (termed risk ratio in Rahmati 1 ). τ 2: between‐study variance. I 2: statistic of between‐study heterogeneity. H 2: statistic of between‐study heterogeneity (=1/(1 − I 2)). Q, p: Cochran's Q statistic for testing heterogeneity between studies and corresponding p value. z, p: z‐statistic for testing the hypothesis of a zero pooled effect and corresponding p value. Qb, p: test statistic for testing between‐group differences of the pooled effect and corresponding p value.
See this image and copyright information in PMC

Comment on

References

    1. Rahmati M, Keshvari M, Mirnasuri S, et al. The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: a systematic review and meta‐analysis. J Med Virol. 2022;94:5112‐5127. 10.1002/jmv.27996 - DOI - PMC - PubMed
    1. StataCorp . Stata: Release 17. Statistical Software. StataCorp LLC; 2021. Stata Meta‐analysis Reference Manual Release 1. https://www.stata.com/manuals/meta.pdf
    1. Lee MS, Lee R, Ko CW, Moon JE. Increase in blood glucose level and incidence of diabetic ketoacidosis in children with type 1 diabetes mellitus in the Daegu‐Gyeongbuk area during the coronavirus disease 2019 (COVID‐19) pandemic: a retrospective crosssectional study. J Yeungnam Med Sci. 2022;39(1):46‐52. - PMC - PubMed
    1. Hernández Herrero M, Terradas Mercader P, Latorre Martinez E, Feliu Rovira A, Rodríguez Zaragoza N, Parada Ricart E. Nuevos diagnósticos de diabetes mellitus tipo 1 en niños durante la pandemia COVID‐19. estudio multicéntrico regional en españa. Endocrinología, Diabetes y Nutrición. 2022;69:709‐714. 10.1016/j.endinu.2021.12.003 - DOI - PMC - PubMed
    1. Salmi H, Heinonen S, Hästbacka J, et al. New‐onset type 1 diabetes in Finnish children during the COVID‐19 pandemic. Arch Dis Child. 2022;107(2):180‐185. - PubMed